NO20003234D0 - Oralt administrerbare ribavirin-doseformer i fast form og fremgangsmÕte for fremstilling av disse - Google Patents

Oralt administrerbare ribavirin-doseformer i fast form og fremgangsmÕte for fremstilling av disse

Info

Publication number
NO20003234D0
NO20003234D0 NO20003234A NO20003234A NO20003234D0 NO 20003234 D0 NO20003234 D0 NO 20003234D0 NO 20003234 A NO20003234 A NO 20003234A NO 20003234 A NO20003234 A NO 20003234A NO 20003234 D0 NO20003234 D0 NO 20003234D0
Authority
NO
Norway
Prior art keywords
preparation
dosage forms
solid form
orally administered
administered ribavirin
Prior art date
Application number
NO20003234A
Other languages
English (en)
Other versions
NO20003234L (no
Inventor
Stephen M Liebowitz
Elliot I Stupak
Imtiaz A Chaudry
Winston A Vadino
Frank E Bowen
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003234(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/997,172 external-priority patent/US5914128A/en
Priority claimed from US08/997,169 external-priority patent/US5916594A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20003234D0 publication Critical patent/NO20003234D0/no
Publication of NO20003234L publication Critical patent/NO20003234L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
NO20003234A 1997-12-22 2000-06-21 Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse NO20003234L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/997,172 US5914128A (en) 1997-12-22 1997-12-22 Orally administrable solid dosage form
US08/997,169 US5916594A (en) 1997-12-22 1997-12-22 Process of making solid ribavirin dosage forms
PCT/US1998/026222 WO1999032128A1 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Publications (2)

Publication Number Publication Date
NO20003234D0 true NO20003234D0 (no) 2000-06-21
NO20003234L NO20003234L (no) 2000-08-21

Family

ID=27130673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003234A NO20003234L (no) 1997-12-22 2000-06-21 Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse

Country Status (27)

Country Link
US (3) US6337090B1 (no)
EP (2) EP0991415B1 (no)
JP (2) JP2001526234A (no)
KR (1) KR100575389B1 (no)
CN (1) CN1155388C (no)
AR (1) AR008977A1 (no)
AT (1) ATE234103T1 (no)
AU (1) AU762826B2 (no)
BR (1) BR9814367A (no)
CA (4) CA2365412C (no)
CO (1) CO4970774A1 (no)
DE (1) DE69812094T2 (no)
DK (1) DK0991415T3 (no)
ES (1) ES2191987T3 (no)
HK (1) HK1034674A1 (no)
HU (1) HUP0100433A3 (no)
IL (1) IL136549A (no)
MY (1) MY119656A (no)
NO (1) NO20003234L (no)
NZ (1) NZ504994A (no)
PE (1) PE20000066A1 (no)
PL (1) PL190267B1 (no)
PT (1) PT991415E (no)
SK (1) SK284520B6 (no)
TW (1) TW575436B (no)
WO (1) WO1999032128A1 (no)
ZA (1) ZA9811726B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191987T3 (es) * 1997-12-22 2003-09-16 Schering Corp Formas de dosificacion de ribavirina solidas, administrables oralmente, y procedimiento de fabricacion.
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
WO2001066026A2 (en) * 2000-03-06 2001-09-13 Tissuelink Medical, Inc. Fluid delivery system and controller for electrosurgical devices
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
KR20030020137A (ko) * 2001-09-03 2003-03-08 진양제약주식회사 리바비린 건조시럽제
BR0213861A (pt) * 2001-11-02 2004-12-21 Sandoz Ag Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida
DE10227148A1 (de) * 2002-06-18 2004-01-08 Biopartners Gmbh Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
AU2004224575A1 (en) * 2003-03-28 2004-10-07 Pharmasset Ltd. Compounds for the treatment of flaviviridae infections
TR200701424T1 (tr) * 2004-09-09 2007-04-24 Bayer Healthcare Ag Suda çözünebilen katı dozaj formunda farmasötik bileşim.
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
EP1917301B1 (en) * 2005-08-05 2014-04-23 3M Innovative Properties Company Compositions exhibiting improved flowability
WO2008063727A2 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
US9072664B2 (en) * 2008-05-22 2015-07-07 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
WO2009158300A1 (en) * 2008-06-26 2009-12-30 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
WO2010002613A2 (en) * 2008-07-02 2010-01-07 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
US10363453B2 (en) 2011-02-07 2019-07-30 New Balance Athletics, Inc. Systems and methods for monitoring athletic and physiological performance
CA2752008A1 (en) 2011-09-13 2013-03-13 Universite De Montreal Combination therapy using ribavirin as elf4e inhibitor
CN106389363A (zh) * 2016-10-18 2017-02-15 广东肇庆星湖生物科技股份有限公司 一种利巴韦林口服固体制剂及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
DE2735600A1 (de) * 1977-08-06 1979-02-15 Dynamit Nobel Ag Verfahren zur herstellung von phthalid
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63216820A (ja) * 1987-03-05 1988-09-09 Chugai Pharmaceut Co Ltd 抗ウイルス剤
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
JP2908844B2 (ja) * 1990-06-29 1999-06-21 ヤマサ醤油株式会社 抗ウイルス剤
JPH07502740A (ja) * 1992-01-06 1995-03-23 ザ・ウエルカム・ファウンデーション・リミテッド 治療用ヌクレオシド
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
JPH06298665A (ja) * 1993-04-14 1994-10-25 Toray Ind Inc 抗ウイルス剤
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5492692A (en) * 1993-08-17 1996-02-20 University Of Kentucky Research Foundation Coated products with potent anti-HIV and antimicrobial properties
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2135669A1 (en) * 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
ES2181868T3 (es) * 1995-02-28 2003-03-01 Aventis Pharma Inc Composicion farmaceutica para compuestos de piperidinoalcanol.
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
ES2191987T3 (es) * 1997-12-22 2003-09-16 Schering Corp Formas de dosificacion de ribavirina solidas, administrables oralmente, y procedimiento de fabricacion.
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms

Also Published As

Publication number Publication date
CN1283117A (zh) 2001-02-07
TW575436B (en) 2004-02-11
ES2191987T3 (es) 2003-09-16
CN1155388C (zh) 2004-06-30
ZA9811726B (en) 1999-06-21
KR100575389B1 (ko) 2006-05-03
EP0991415B1 (en) 2003-03-12
CO4970774A1 (es) 2000-11-07
PL341230A1 (en) 2001-03-26
CA2365412C (en) 2002-09-17
SK284520B6 (sk) 2005-05-05
CA2365412A1 (en) 1999-07-01
DK0991415T3 (da) 2003-06-16
HK1034674A1 (en) 2001-11-02
NZ504994A (en) 2002-10-25
WO1999032128A1 (en) 1999-07-01
US6335032B1 (en) 2002-01-01
MY119656A (en) 2005-06-30
CA2323849C (en) 2002-06-11
JP2006083189A (ja) 2006-03-30
CA2323849A1 (en) 1999-07-01
AR008977A1 (es) 2000-03-08
DE69812094D1 (de) 2003-04-17
SK8942000A3 (en) 2001-04-09
EP1321147A1 (en) 2003-06-25
EP0991415A1 (en) 2000-04-12
CA2300452C (en) 2000-11-28
HUP0100433A3 (en) 2003-01-28
CA2300452A1 (en) 1999-07-01
CA2287056A1 (en) 1999-07-01
US6051252A (en) 2000-04-18
IL136549A (en) 2005-05-17
JP2001526234A (ja) 2001-12-18
HUP0100433A2 (hu) 2001-12-28
IL136549A0 (en) 2001-06-14
PT991415E (pt) 2003-06-30
AU762826B2 (en) 2003-07-03
BR9814367A (pt) 2000-10-17
AU2199199A (en) 1999-07-12
KR20010033441A (ko) 2001-04-25
PL190267B1 (pl) 2005-11-30
NO20003234L (no) 2000-08-21
DE69812094T2 (de) 2003-12-24
CA2287056C (en) 2000-08-15
ATE234103T1 (de) 2003-03-15
PE20000066A1 (es) 2000-02-09
US6337090B1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
NO20003234D0 (no) Oralt administrerbare ribavirin-doseformer i fast form og fremgangsmÕte for fremstilling av disse
IS5526A (is) 11ß-Halógen-7alfa-setin estratríen, aðferð til framleiðslu á lyfjasamsetningum sem innihalda fyrrnefnd estratríen og notkun þeirra til framleiðslu á læknislyfjum
NO993315D0 (no) Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
DE69618587T2 (de) Chinazoline und pharmazeutische zusammensetzungen
ATE318616T1 (de) Wasserlösliches hedgehog-protein im ionischen komplex und deren pharmazeutische verwendung
EE04293B1 (et) Stabiilsed lüofiliseeritud ravimvormid
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
PT869126E (pt) Derivados de ditiolano, sua preparacao e seus efeitos terapeuticos
BR9506119A (pt) Composição farmacêutica e forma de dosagem farmacêutica unitária
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO20010277D0 (no) Benzocykloheptener, fremgangsmåte for fremstilling derav, farmasöytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
ID16283A (id) Senyawa yang berguna dibidang farmasi
NO20016068D0 (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasöytisk preparat for redusering av inflammasjon i et dyr
NO20015659D0 (no) Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
NO20002526L (no) Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav
IT1277835B1 (it) Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
NO20012518D0 (no) Fremgangsmåte ved fremstilling av legemidler i fast administrasjonsform
ATE186559T1 (de) Leukoindigo-präparationen in granulatform
DE19681529D2 (de) Pharmazeutische Darreichungsform
IS4740A (is) Nýjar kínoxalindíón afleiður, framleiðsla þeirra og notkun í læknislyf
NO305792B1 (no) Substituerte benzensulfonylureaer, deres anvendelse for fremstilling av farmas°ytiske preparater og medikamenter inneholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application